Skip to main content

Table 1 Summary of results

From: Changes in specialized blood vessels in lymph nodes and their role in cancer metastasis

HEV parameters

Clinical data

Relative risk

p

95% Confidence interval

Total no. of HEV (A)

Overall Survival

1.024

0.471

0.961 ~ 1.091

 

Disease Free Interval

1.051

0.022

1.007 ~ 1.097

Total no. of HEV (A) and Disease Free Interval (as a Cohort)

Disease Free Interval

1.051

0.023

1.007 ~ 1.096

Dilated HEV (B)

Overall Survival

1.071

0.476

0.886 ~ 1.295

 

Disease Free Interval

1.034

0.594

0.915 ~ 1.169

HEV with RBC within its lumen (C)

Overall Survival

1.116

0.345

0.889 ~ 1.401

 

Disease Free Interval

1.044

0.584

0.896 ~ 1.216

Ratio of dilated HEVs to the total no. of HEV(B/A)

Overall Survival

1.078

0.982

0.002 ~ 638.23

 

Disease Free Interval

10.10

0.450

0.001 ~ 39.89

Ratio of dilated HEVs with RBC to total no. HEV (C/A)

Overall Survival

3.624

0.737

0.002 ~ 6634.42

 

Disease Free Interval

4.67

0.643

0.001 ~ 145.83

Ratio of dilated HEVs with RBC within its lumen to total no. of dilated HEV (C/B)

Overall Survival

17.884

0.171

0.287 ~ 1114.67

 

Disease Free Interval

5.458

0.208

0.389 ~ 76.616